Initiatives for Improving Access to Medicines for Non-communicable Diseases

Flexible Pricing Policy in Emerging and Developing Countries

In addition to the patient contribution through innovative new drug development and sales, Ӱҵhas established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.

Approval Status of Global Products

Ӱҵstrives to bring products to many patients who need them all over the world. Please visit to see the approval status of Ӱҵglobal products in each country and region.